Features of treatment of patients with rheumatic heart diseases in real clinical practice
In article the analysis of treatment of patients with rheumatic heart diseases according to prospective researches of the same persons in 2001 and 2005 is presented. It is established, that the share of application of inhibitors of angiotensin-transforming of enzyme, antagonists АТ1-receptors of angiotensin, beta-blokcers, antagonists aldosterons has increased, cardiac glycozids and diuretics stayed at the same level.